Prelude Therapeutics
1.04
0.02 (1.96%)
At close: Jan 15, 2025, 2:33 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -2.12 -2.67 -5.35 -54.93 -30.79 -57.3
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 1.09 1.46 2.07 14.74 -17.18 -37.07
P/FCF Ratio -2.33 -3.3 -6.9 -66.82 -32.1 -62.39
P/OCF Ratio -2.41 -3.42 -7.09 -67.72 -33.08 -64.94
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.07 0.01 0.01 n/a -0.01 n/a
Quick Ratio 10.79 9.42 15.37 19.41 4.18 6.37
Current Ratio 10.79 9.42 15.37 19.41 4.18 6.37
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.51 -0.55 -0.39 -0.27 0.56 0.65
Return on Assets (ROA) -0.44 -0.49 -0.36 -0.25 -1.26 -0.89
Return on Capital (ROIC) -0.52 -0.62 -0.4 -0.28 -1.65 -1.07
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a